Stage IV Prostate Cancer AJCC v7
Information
- Disease name
- Stage IV Prostate Cancer AJCC v7
- Disease ID
- Description
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
| Genes | Mutation | Description | Source | Links |
|---|
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT01480154 | Active, not recruiting | Phase 1 | Akt Inhibitor MK2206 and Hydroxychloroquine in Treating Patients With Advanced Solid Tumors, Melanoma, Prostate or Kidney Cancer | November 23, 2011 | March 7, 2025 |
| NCT02522715 | Active, not recruiting | Phase 1/Phase 2 | Enzalutamide and Cabazitaxel in Treating Patients With Metastatic, Castration-Resistant Prostate Cancer | October 13, 2015 | July 1, 2024 |
| NCT01638533 | Active, not recruiting | Phase 1 | Romidepsin in Treating Patients With Lymphoma, Chronic Lymphocytic Leukemia, or Solid Tumors With Liver Dysfunction | June 12, 2012 | March 5, 2025 |
| NCT00064129 | Completed | Phase 1 | Ipilimumab and Sargramostim in Treating Patients With Metastatic Prostate Cancer | May 13, 2003 | October 1, 2012 |
| NCT00942331 | Completed | Phase 3 | Gemcitabine Hydrochloride and Cisplatin With or Without Bevacizumab in Treating Patients With Advanced Urinary Tract Cancer | July 15, 2009 | June 15, 2021 |
| NCT01576172 | Completed | Phase 2 | Abiraterone Acetate and Prednisone With or Without Veliparib in Treating Patients With Metastatic Castration-Resistant Prostate Cancer | March 30, 2012 | April 23, 2020 |
| NCT02849990 | Completed | Phase 2 | A Phase II Neoadjuvant Study of Apalutamide, Abiraterone Acetate, Prednisone, Degarelix and Indomethacin in Men With Localized Prostate Cancer Pre-prostatectomy | March 9, 2017 | December 10, 2020 |
| NCT03368547 | Completed | N/A | 68Ga-PSMA-11 PET/CT in Imaging Patients With Intermediate or High Risk Prostate Cancer Before Surgery | December 12, 2016 | June 18, 2021 |
| NCT03421782 | Completed | Phase 2 | Fatigue Interventions in Cancer (Exercise Intervention) | February 26, 2018 | August 8, 2022 |
| NCT03448458 | Completed | Phase 2 | Gallium Ga 68-DOTATATE PET/CT in Diagnosing Patients With Metastatic Castration Resistant Prostate Cancer | February 22, 2018 | February 6, 2023 |
| NCT02555189 | Completed | Phase 1/Phase 2 | Enzalutamide With Ribociclib in Treating Patients With Metastatic Castrate-Resistant, Chemotherapy Naive Prostate Cancer That Retains Retinoblastoma Expression | December 1, 2015 | September 1, 2023 |
| NCT01050504 | Recruiting | Collecting and Studying Blood and Tissue Samples From Patients With Locally Recurrent or Metastatic Prostate or Bladder/Urothelial Cancer | August 2009 | January 31, 2029 | |
| NCT05334069 | Recruiting | Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection | August 1, 2022 | February 2025 | |
| NCT04775355 | Recruiting | Study to Detect Changes in Urinary and Gut Microbiome During Androgen Deprivation Therapy and Radiation Therapy in Patients With Prostate Cancer | April 14, 2021 | July 29, 2025 | |
| NCT02565901 | Terminated | Phase 1/Phase 2 | Sirolimus, Docetaxel, and Carboplatin in Treating Patients With Metastatic Castration-Resistant Prostate Cancer | February 29, 2016 | June 16, 2020 |